BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26212097)

  • 1. Allosterism in human complement component 5a ((h)C5a): a damper of C5a receptor (C5aR) signaling.
    Rana S; Sahoo AR; Majhi BK
    J Biomol Struct Dyn; 2016 Jun; 34(6):1201-13. PubMed ID: 26212097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling.
    Rana S; Sahoo AR; Majhi BK
    Mol Biosyst; 2016 Apr; 12(5):1586-99. PubMed ID: 26978009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered
    Sahoo AR; Mishra R; Rana S
    Sci Rep; 2018 Feb; 8(1):2955. PubMed ID: 29440703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
    Lee H; Whitfeld PL; Mackay CR
    Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
    Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
    J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of C5a-C5aR axis in the development of atherosclerosis.
    An G; Ren G; An F; Zhang C
    Sci China Life Sci; 2014 Aug; 57(8):790-4. PubMed ID: 25104451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthosteric and allosteric action of the C5a receptor antagonists.
    Liu H; Kim HR; Deepak RNVK; Wang L; Chung KY; Fan H; Wei Z; Zhang C
    Nat Struct Mol Biol; 2018 Jun; 25(6):472-481. PubMed ID: 29867214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
    Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
    FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2.
    Croker DE; Halai R; Fairlie DP; Cooper MA
    Immunol Cell Biol; 2013; 91(10):625-33. PubMed ID: 24060963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of C5a receptors.
    Ward PA
    J Mol Med (Berl); 2009 Apr; 87(4):375-8. PubMed ID: 19189071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C5L2, a nonsignaling C5A binding protein.
    Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
    Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.
    Bamberg CE; Mackay CR; Lee H; Zahra D; Jackson J; Lim YS; Whitfeld PL; Craig S; Corsini E; Lu B; Gerard C; Gerard NP
    J Biol Chem; 2010 Mar; 285(10):7633-44. PubMed ID: 20044484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
    Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
    Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
    J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.
    Nishiura H; Zhao R; Yamamoto T
    J Biochem; 2011 Sep; 150(3):271-7. PubMed ID: 21613290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
    Cain SA; Monk PN
    J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational search for discovering potential neutraligands of human complement fragment 5a (
    Mishra R; Rana S
    Bioorg Med Chem; 2019 Oct; 27(19):115052. PubMed ID: 31447248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolutionary analysis of complement component C5 and the gene co-expression network and putative interaction between C5a and C5a anaphylatoxin receptor (C5AR/CD88) in human and two Cyprinid fish.
    Li L; Yang W; Shen Y; Xu X; Li J
    Dev Comp Immunol; 2021 Mar; 116():103958. PubMed ID: 33290783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
    Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.